sign up log in
Want to go ad-free? Find out how, here.

Colin Green

Andrew Patterson meets a kiwi bio-tech company which has raised $74 million developing a therapeutic drug here for international markets
Andrew Patterson meets a kiwi bio-tech company which has raised $74 million developing a therapeutic drug here for international markets